Pembrolizumab-combination therapy for previously untreated metastatic nonsquamous NSCLC: Real-world outcomes at US oncology practices

OBJECTIVES: The availability of immunotherapies has expanded the options for treating metastatic NSCLC, but information is needed regarding outcomes of immunotherapy for patients treated outside of clinical trials. The aim of this retrospective study was to evaluate the outcomes of therapy with firs...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Stephen V., Hu, Xiaohan, Li, Yeran, Zhao, Bin, Burke, Thomas, Velcheti, Vamsidhar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618586/
https://www.ncbi.nlm.nih.gov/pubmed/36324586
http://dx.doi.org/10.3389/fonc.2022.999343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618586/
https://www.ncbi.nlm.nih.gov/pubmed/36324586
http://dx.doi.org/10.3389/fonc.2022.999343

Ejemplares similares